Discover a stage-by-stage quick guide to ADC discovery, covering target selection, antibody discovery platform selection, parental antibody production, early developability assessment, in vitro assays, and in vivo pharmacology, backed by practical considerations across each stage to support informed decision-making and preclinical progression.
ADC Drug Discovery: Target Biology, Antibody Discovery, and In Vitro & In Vivo Characterization
30 September, 2026
Watch this next
Panel Discussion: Mastering Stability & Characterisation: Building Confidence In Protein & Antibody Therapeutics From Bench To Batch
Christian Hunzinger
BioNTech
Fabio Centola
Merck KGaA
Dennis Ungan
Novartis
Market Insight
Jul, 2026
Panel Discussion: Next-Generation Biomed: AI, Science, Or The People Behind – What Will Actually Scale?
Russell Lamontagne
Boston Immune Technologies
Yashas Kannan
PentaBind
Catherine Stace
Kuano
Market Insight
Jul, 2026
Panel Discussion: Next-Generation Modalities & Biotherapeutics: From Idea To Implementation
Miguel Gaspar
AstraZeneca
Steve Hood
GSK
Christopher Herring
T-Therapeutics
Michelle Barnard
ValiRx
Jennifer Mataraza
Novartis
Market Insight
Jul, 2026
You're just a click away
To access our site, please accept the Terms of Use - our full terms of use are available below.
Full Terms of Use
By rejecting you won't be able to progress to the LifeScienceXchange platform.







